Mimedx (MDXG) Gross Margin Growth (1y) (2012 - 2026)
Mimedx (MDXG) Gross Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 236.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 228.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 6.06 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -475.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1,034.00 |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | -1,210.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,210.00 |
| Mar 31, 2026 | -1,067.00 |
| Dec 31, 2025 | 206.00 |
| Sep 30, 2025 | 177.00 |
| Jun 30, 2025 | -191.00 |
| Mar 31, 2025 | -344.00 |
| Dec 31, 2024 | -226.00 |
| Sep 30, 2024 | -13.00 |
| Jun 30, 2024 | -32.00 |
| Mar 31, 2024 | 200.00 |
| Dec 31, 2023 | 338.00 |
| Sep 30, 2023 | -9.00 |
| Jun 30, 2023 | 96.00 |
| Mar 31, 2023 | -46.00 |
| Dec 31, 2022 | -535.00 |
| Sep 30, 2022 | -195.00 |
| Jun 30, 2022 | 104.00 |
| Mar 31, 2022 | -79.00 |
| Dec 31, 2021 | 181.00 |
| Sep 30, 2021 | -6.00 |